Medivir AB said it completed a placing with existing shareholders raising SEK 224.5 million (Euros24.5 million) before costs. The issue was fully subscribed, with 99.3 percent of the shares taken up by those with preferential rights.
Following the fundraising there are 660, 000 class A shares and 20 million class B shares in issue.
The new shares will be traded on the Nordic list of the Stockholm Stock Exchange from 28th February 2007.
Follow where the public and private R&I money is going and which collaborative opportunities you can pursue.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
Sign up for the Funding Newswire
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
